SCHEMBL6875492

SCHEMBL6875492

COCCN(C)c1ccc(OC)c(N)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 1/20 0.46
▸ ALDH1A1 P00352 5/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ MAPT P10636 1/20 0.43
▸ THRB P10828 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ LMNA P02545 1/20 0.40
▸ HTT P42858 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ TDP1 Q9NUW8 2/20 0.38
▸ APP P05067 1/20 0.38
▸ ADK P55263 1/20 0.38
▸ AOC3 Q16853 1/20 0.37
▸ NTSR1 P30989 1/20 0.37
▸ DHFR P00374 1/20 0.36
▸ TUBB4A P04350 1/20 0.36
▸ TUBB P07437 1/20 0.36
▸ TUBA3C P0DPH7 1/20 0.36
▸ TUBA1B P68363 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30682408 0.87 ALDH1A1 (0.47) ALDH1A1CYP3A4MEN1MAPTTHRB
SCHEMBL10420297 0.79 S100B (0.50) ALDH1A1CYP3A4TDP1ADKNTSR1
SCHEMBL12674298 0.78 USP1 (0.35) GAAALDH1A1CYP3A4HTTTDP1
SCHEMBL12666655 0.78 BRAF (0.32) CYP3A4LMNAHTTNTSR1
SCHEMBL10208072 0.77 ALDH1A1 (0.55) GAAALDH1A1CYP3A4MEN1MAPT
SCHEMBL18562081 0.76 BRAF (0.41) ALDH1A1MEN1MAPTKMT2AHTT
SCHEMBL3039281 0.75 TDP1 (0.46) ALDH1A1CYP3A4MAPTL3MBTL1TDP1
SCHEMBL6872660 0.75 SMN1; SMN2 (0.48) GAAALDH1A1CYP3A4MEN1MAPT
SCHEMBL12288117 0.75 MAPT (0.48) ALDH1A1MEN1MAPTKMT2ALMNA
SCHEMBL5713569 0.75 KMT2A (0.37) GAAALDH1A1MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6713499-B2 ADENOSINE RECEPTOR AGONIST HOFFMAN-LA ROCHE INC. 2004-03-30 — — US disclosed
US-20030153566-A1 7-Amino-benzothiazole derivatives F. HOFFMANN-LA ROCHE AG (CH) 2003-08-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030153566-A1 7-Amino-benzothiazole derivatives ADORA1, ADORA2A, ADORA3 GAA 2652/4885ALDH1A1 308/4885CYP3A4 954/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback